An investigation of the University of Duke, in the United States, carried out by biomedical engineers and published in the journal Nature Biomedical Engineering, has managed to develop a regulated insulin release tool that could make the treatment of diabetes injections monthly, whichIt is currently weekly or daily.
This mechanism consists of a biopolymer that reacts with the heat of the human body and that can be administered through a current hypodermic needle.Once this reaction occurs, that element becomes a biodegradable gel that gradually releases the corresponding medication as dissolved.
In the experiments that the researchers conducted with animals, glucose control demonstrated a duration of three times greater than the treatments available today.In this sense, glucose control in mice with this new method lasted for ten days with only one dose, compared to the two or three that allow current tools.
Thanks to this controlled release biopolymer, the researchers, by reducing the number of injections required, pursue, in turn, the objective of reducing the patient's mistake factor or the action of the antibodies of the immune system before the repetition before the repetitionfrequent of such treatments.
On the other hand, the authors of the study affirm that, thanks to the reduction of costs and the few production expenses that it entails, this tool can be conducive to its application in third world countries or in development.
